HDAC inhibitor Nexturastat A, Purity ≥98%

Cat. No.: X23-10-ZQ305

HDAC inhibitor Nexturastat A, Purity ≥98%

Synonym: 1403783-31-2; Nexturastat A; 4-((1-Butyl-3-phenylureido)methyl)-N-hydroxybenzamide; Nexturastata; s7473; HDAC inhibitor

  • MDL: MFCD28099804
  • CAS Number: 1403783-31-2
  • Compound CID: 71462653
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Nexturastat A, soluble in DMSO and ethanol and insoluble in water, induces DNA damage and the inhibition of DNA repair processes. It targets HDAC6.
Molecular Weight
341.40422
Molecular Formula
C19H23N3O3
Targets
HDAC6: 5 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 59 mg/mL (172.81 mM); Water: Insoluble; Ethanol: 2 mg/mL (5.85 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Nexturastat A is used to investigate its selective inhibition of HDAC6, particularly in research focused on neurodegenerative diseases and cancer.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.